blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability
Register Forum

2022.02.11

More...
blank News flashes

News Flashes

New version of the European Patent Register – SPC proceedings information in the Unitary Patent Register.

2024-07-24

More...
blank Related links

Extract from the Register of European Patents

EP About this file: EP0568437

EP0568437 - Antidepressant 3-Halophenylpiperazinyl-propyl Derivatives of Substituted Triazolones and Triazoldiones [Right-click to bookmark this link]
StatusNo opposition filed within time limit
Status updated on  28.12.2001
Database last updated on 31.08.2024
Most recent event   Tooltip17.04.2015Change - lapse in a contracting statepublished on 20.05.2015  [2015/21]
Applicant(s)For all designated states
Bristol-Myers Squibb Company
Route 206 and Province Line Road
Princeton, NJ 08543 / US
[N/P]
Former [1993/44]For all designated states
Bristol-Myers Squibb Company
345 Park Avenue
New York, N.Y. 10154 / US
Inventor(s)01 / Mayol, Robert F.
56 Green Lane
Durham, Connecticut 06422 / US
02 / Luke, George M.
5849 Winacre Drive
LaFayette, New York 13084 / US
[1993/44]
Representative(s)Bentz, Jean-Paul, et al
Cabinet Weinstein
56A Rue du Faubourg Saint-Honoré
75008 Paris / FR
[N/P]
Former [2001/03]Bentz, Jean-Paul, et al
Cabinet Weinstein, 56 A, rue du Faubourg Saint-Honoré
75008 Paris / FR
Former [1993/44]Durand, Yves Armand Louis, et al
CABINET WEINSTEIN 20, Avenue de Friedland
F-75008 Paris / FR
Application number, filing date93401083.626.04.1993
[1993/44]
Priority number, dateUS1992087504428.04.1992         Original published format: US 875044
[1993/44]
Filing languageEN
Procedural languageEN
PublicationType: A1 Application with search report 
No.:EP0568437
Date:03.11.1993
Language:EN
[1993/44]
Type: B1 Patent specification 
No.:EP0568437
Date:21.02.2001
Language:EN
[2001/08]
Search report(s)(Supplementary) European search report - dispatched on:EP23.08.1993
ClassificationIPC:C07D249/12, A61K31/41, A61K31/495
[1993/44]
CPC:
C07D249/12 (EP,US); A61P25/24 (EP); A61P25/26 (EP)
Designated contracting statesAT,   BE,   CH,   DE,   DK,   ES,   FR,   GB,   GR,   IE,   IT,   LI,   LU,   MC,   NL,   PT,   SE [1993/44]
TitleGerman:Antidepressiv wirkende 3-Halophenylpiperazinyl-Propylderivate von substituierten Triazolonen und Triazoldionen[1993/44]
English:Antidepressant 3-Halophenylpiperazinyl-propyl Derivatives of Substituted Triazolones and Triazoldiones[1993/44]
French:Dérivés antidépresseurs 3-halophénylpiperazinyl propyl de triazolones et triazoldiones substituées[2000/37]
Former [1993/44]Dérivés antidépressifs 3-halophénylpiperazinyl propyl de traizolones et triazoldiones substituées
Examination procedure29.04.1994Examination requested  [1994/26]
25.01.1995Despatch of a communication from the examining division (Time limit: M06)
21.07.1995Reply to a communication from the examining division
29.08.1996Despatch of a communication from the examining division (Time limit: M06)
03.03.1997Reply to a communication from the examining division
30.10.1997Despatch of a communication from the examining division (Time limit: M06)
18.03.1998Reply to a communication from the examining division
14.01.1999Despatch of a communication from the examining division (Time limit: M06)
18.06.1999Reply to a communication from the examining division
31.03.2000Despatch of communication of intention to grant (Approval: No)
20.07.2000Despatch of communication of intention to grant (Approval: later approval)
01.08.2000Communication of intention to grant the patent
30.10.2000Fee for grant paid
30.10.2000Fee for publishing/printing paid
Opposition(s)22.11.2001No opposition filed within time limit [2002/07]
Fees paidRenewal fee
03.03.1995Renewal fee patent year 03
07.03.1996Renewal fee patent year 04
12.04.1997Renewal fee patent year 05
14.04.1998Renewal fee patent year 06
14.04.1999Renewal fee patent year 07
13.04.2000Renewal fee patent year 08
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court
See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Former [2007/16]LU30.04.2001
Documents cited:Search[AD]US4338317  (TEMPLE JR DAVIS L, et al);
 [AD]US4613600  (GAMMANS RICHARD E [US], et al);
 [XP]EP0493687  (BRISTOL MYERS SQUIBB CO [US])
 [A]  - JOURNAL OF CHROMATOGRAPHY vol. 570, no. 1, 1991, pages 129 - 138 FRANC JE ET AL. 'High-performance liquid chromatographic method for the determination of nefazodone and its metabolites in human plasma using laboratory robotics'
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.